My patient has stage IIIA (N2) disease: Surgery or radiotherapy? Multidisciplinary Tumour Board

My patient needs chemoradiotherapy and durvalumab

Lecture Time
15:34 - 16:01
Speakers
  • D. De Ruysscher (Maastricht, Netherlands)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • D. De Ruysscher (Maastricht, Netherlands)
Early detection, screening, prevention Educational session

Q&A

Lecture Time
15:21 - 15:24
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Early detection, screening, prevention Educational session

Primary prevention European campaigns

Lecture Time
14:30 - 14:45
Speakers
  • S. Novello (Orbassano, Italy)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • S. Novello (Orbassano, Italy)
Current management of early stage NSCLC Educational session

Early stage lung cancer: Progress in TNM

Lecture Time
14:30 - 14:50
Speakers
  • R. Rami-Porta (Terrassa, Barcelona, Spain)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • R. Rami-Porta (Terrassa, Barcelona, Spain)
Early detection, screening, prevention Educational session

Early detection of mesothelioma and lung cancer in ultra-high risk populations using a biomarker approach

Lecture Time
15:24 - 15:39
Speakers
  • T. Behrens (Bochum, Germany)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
14:30 - 16:00
Authors
  • T. Behrens (Bochum, Germany)
Optimising treatment in stage III Educational session

What is the role of surgery for stage III patients in the I-O era?

Lecture Time
17:10 - 17:30
Speakers
  • P. Van Schil (Edegem, Belgium)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • P. Van Schil (Edegem, Belgium)
Proffered Paper session I Proffered Paper session

Invited Discussant 68O and 69O

Lecture Time
17:00 - 17:15
Speakers
  • A. Dingemans (Maastricht, Netherlands)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:15
Authors
  • A. Dingemans (Maastricht, Netherlands)
NSCLC stage IV oncogenic addicted disease Educational session

Targeted therapy beyond EGFR, ALK and ROS1

Lecture Time
17:10 - 17:30
Speakers
  • D. Planchard (Villejuif, France)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • D. Planchard (Villejuif, France)
Optimising treatment in stage III Educational session

Innovative radiotherapy approaches for stage III NSCLC patients

Lecture Time
17:30 - 17:50
Speakers
  • H. Choy (Dallas, TX, United States of America)
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • H. Choy (Dallas, TX, United States of America)
Proffered Paper session I Proffered Paper session

Invited Discussant 83O, LBA2 and LBA4

Lecture Time
18:00 - 18:15
Speakers
  • F. Barlesi (Marseille, CEDEX 20, France)
Location
Room C, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:15
Authors
  • F. Barlesi (Marseille, CEDEX 20, France)
NSCLC stage IV oncogenic addicted disease Educational session

Immunotherapy in oncogenic addicted NSCLC

Lecture Time
17:30 - 17:50
Speakers
  • J. Mazieres (Toulouse, France)
Location
Room B, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00
Authors
  • J. Mazieres (Toulouse, France)
Optimising treatment in stage III Educational session

Q&A

Lecture Time
17:50 - 18:00
Location
Room A, Geneva Palexpo, Geneva, Switzerland
Date
Wed, 10.04.2019
Time
16:30 - 18:00